Debut Plus

₹29.99

▼ -0.06 -0.20%

As of 23 Oct 2026 · delayed

BSE Listed

SDD
What does SDD mean?
BSE · Structured Digital Database (SDD) Non-ComplianceA governance red flag, not a price measure: the company cannot demonstrate it tracks who holds its unpublished price-sensitive information — the core defence against insider leaks. Practical meaning: fix the SDD register and compliance-officer process fast; the flag is publicly visible on the quote page and persistent non-compliance escalates to fines.Criteria: Company has not maintained / certified the Structured Digital Database required under SEBI (Prohibition of Insider Trading) Regulations — the register of persons with access to unpublished price-sensitive information. Flagged per-scrip on the exchange quote page; a governance red flag that draws exchange fines and closer surveillance.Exchange notice · 2026-07-18

Kimia Biosciences Limited (530313)

Volume: 1,361Avg Vol 1W: 1,250Avg Vol 1M: 3,34152W Range:₹23.2₹43.28
Market Cap₹142 Cr
Current Price₹29.99
Previous Close₹30.05
High / Low (52w)₹43.28 / ₹23.2
Volume1,361
Avg Vol (1W)1,250
Avg Vol (1M)3,341
Stock P/E19.73
Book Value₹3.75
Dividend Yield0%
ROE41.95%
ROA6.97%
Revenue (TTM)—
Revenue Growth—
Profit Margin6.42%
Total Debt—
Shares Outstanding5 Cr
Face Value—
EPS (TTM)₹1.52
P/B8.01
Debt / Equity2.45
50 DMA₹30.06
200 DMA₹31.99
Day change-0.20%
SurveillanceSDD
Price Chart
₹29.99▼ 11.25% · 1Y
₹46₹241.2L
2025-10-27
2026-10-23

20-day avg volume: 4K shares

Pros
  • Healthy return on equity of 42.0%.
  • Company is almost debt-free.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹28 Cr₹30 Cr₹38 Cr₹24 Cr₹34 Cr₹30 Cr₹27 Cr₹21 Cr
EBITDA₹3 Cr₹5 Cr₹8 Cr₹2 Cr₹1 Cr₹6 Cr₹3 Cr₹1 Cr
Net Profit₹2 Cr₹5 Cr₹2 Cr₹1 Cr₹1 Cr₹5 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹95 Cr₹107 Cr₹135 Cr₹126 Cr₹130 Cr₹107 Cr₹120 Cr₹117 Cr
EBITDA₹6 Cr₹4 Cr₹9 Cr₹-1 Cr₹-7 Cr₹-2 Cr₹18 Cr₹12 Cr
Net Profit₹4 Cr₹1 Cr₹5 Cr₹-4 Cr₹-9 Cr₹-5 Cr₹10 Cr₹7 Cr
EPS2.640.291.08-0.78-1.98-1.122.041.64
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹65 Cr₹86 Cr₹107 Cr₹109 Cr₹121 Cr₹100 Cr₹111 Cr₹103 Cr
Total Liabilities₹59 Cr₹72 Cr₹88 Cr₹95 Cr₹116 Cr₹100 Cr₹101 Cr₹85 Cr
Equity₹6 Cr₹13 Cr₹18 Cr₹15 Cr₹5 Cr₹0 Cr₹10 Cr₹18 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹6 Cr₹8 Cr₹-7 Cr₹15 Cr₹21 Cr₹11 Cr
Investing₹-14 Cr₹-1 Cr₹-3 Cr₹-1 Cr₹-5 Cr₹-8 Cr
Financing₹8 Cr₹-8 Cr₹10 Cr₹-13 Cr₹-17 Cr₹-3 Cr
Free Cash Flow₹6 Cr₹8 Cr₹-7 Cr₹15 Cr₹21 Cr₹11 Cr
Shareholding
Promoter 74.94% Institutions 0.38% Public 24.68%
Efficiency & Working Capital
ROCE22.8%
Interest Coverage3.4
Dividend Payout—
Debtor Days93 d
Inventory Days83 d
Payable Days134 d
Cash Conversion Cycle42 d
Working Capital Days177 d
Shareholding Details

As of 2026-09-30

Promoter74.9%
FII0%
DII0.4%
Institutions0.4%
Public24.7%
Promoter Pledge0%
No. of Shareholders12,696
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%
Public24.7%24.7%24.7%24.7%24.7%24.7%24.7%24.7%24.7%24.7%24.7%24.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders12,06312,11012,02312,17912,23112,27812,20012,61612,75112,77512,77512,696
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Sameer GoelShareholding of Promoter and Promoter Group74.9%3.55 Cr
Anish Kumar AggarwalPublic Shareholding4.3%20,50,000
Manish GuptaPublic Shareholding4.3%20,09,820
Roma MittalPublic Shareholding4.1%19,42,288
Rahul AgrawalPublic Shareholding3.3%15,75,870
Santosh GoelShareholding of Promoter and Promoter Group0%32
Vandana GoelShareholding of Promoter and Promoter Group0%0
Vipul GoelShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Sameer GoelChairman / Executive Director / MD / CEO2025
Vipul GoelIndependent Non Exe. Director2025
Jagdeep DhavvanIndependent Non Exe. Director2025
Richa GuptaIndependent Non Exe. Director2025
Segments — Geography
RegionRevenueShare
Within India₹97 Cr81.7%
Outside India₹22 Cr18.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1855
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-10Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202600015923
202600014822
2026000101
Substantial Acquisitions (SAST)

4 disclosure(s)

Off Market / Inter se transfer09/08/2024 · 53,18,395
Off Market / Inter se transfer09/08/2024 · 53,18,395
NULL08/08/2024 · 53,18,395
Transmission02/07/2022 · 53,18,380
Company Information
Incorporated1993
ChairmanSameer Goel
AuditorNeeraj Arora & Associates
Investor Email[email protected]
🌐 www.kimiabiosciences.com ↗

📍 Bhondsi Village, Tehsil Sohna, Gurgaon, Haryana, 122102

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search